Back to search

Article

Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis

2021-05-05

Abstract excerpt

<h4>Introduction</h4> Recent reports of potential harmful effects of nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with Corona Virus Disease 2019 (COVID-19) have provoked great concern. Therefore, the safety of NSAIDs is still questioned. <h4>Methods</h4> We searched the PubMed, EMBASE, Cochrane Library and Web of Science databases from December 2019 to January 2021 to examine use prevalence for NSAIDs...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
357a98ba-1e69-52fe-853a-a1f9f4f97269
DOI
10.1101/2021.05.01.21256428
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysisDOI 10.1101/2021.05.01.21256428
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysisSemantic proximity
OpenSAFELY: Do adults prescribed non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19?Semantic proximity
NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory EffectsSemantic proximity
Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic reviewSemantic proximity
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large State-wide Health System During the Pandemic in 2020Semantic proximity
Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19Semantic proximity
(non-aspirin) NSAIDs use and risk of cardiovascular diseases: A Mendelian randomization studySemantic proximity
Generation of Risk Score for Serious Non-Steroidal Anti-Inflammatory Drug (NSAID) Induced Cardiovascular Events (NAÏVE) among Active-Duty Service Members and VeteransSemantic proximity
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19Semantic proximity
SARS-CoV-2 intervened by NSAIDs: A network pharmacology approach to decipher signaling pathway and interactive genesSemantic proximity
Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replicationSemantic proximity
Select a neighboring publication to make it the new centre.